| Year |
Citation |
Score |
| 2022 |
Roweth HG, Malloy MW, Goreczny GJ, Becker IC, Guo Q, Mittendorf EA, Italiano JE, McAllister SS, Battinelli EM. Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer. Science Advances. 8: eabo5224. PMID 36223471 DOI: 10.1126/sciadv.abo5224 |
0.501 |
|
| 2022 |
Freedman RA, Li T, Sedrak MS, Hopkins JO, Tayob N, Faggen MG, Sinclair NF, Chen WY, Parsons HA, Mayer EL, Lange PB, Basta AS, Perilla-Glen A, Lederman RI, Wong A, ... ... McAllister SS, et al. 'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer. Journal of Geriatric Oncology. PMID 36163163 DOI: 10.1016/j.jgo.2022.09.006 |
0.317 |
|
| 2022 |
Guo Q, Spasic M, Maynard AG, Goreczny GJ, Bizuayehu A, Olive JF, van Galen P, McAllister SS. Clonal barcoding with qPCR detection enables live cell functional analyses for cancer research. Nature Communications. 13: 3837. PMID 35788590 DOI: 10.1038/s41467-022-31536-5 |
0.322 |
|
| 2021 |
Tarantino P, Barroso-Sousa R, Garrido-Castro AC, McAllister SS, Guerriero JL, Mittendorf E, Curigliano G, Tolaney SM. Understanding resistance to immune checkpoint inhibitors in advanced breast cancer. Expert Review of Anticancer Therapy. 22: 141-153. PMID 34919490 DOI: 10.1080/14737140.2022.2020650 |
0.343 |
|
| 2021 |
Goldberg J, Pastorello RG, Vallius T, Davis J, Cui YX, Agudo J, Waks AG, Keenan T, McAllister SS, Tolaney SM, Mittendorf EA, Guerriero JL. The Immunology of Hormone Receptor Positive Breast Cancer. Frontiers in Immunology. 12: 674192. PMID 34135901 DOI: 10.3389/fimmu.2021.674192 |
0.534 |
|
| 2020 |
Guo Q, Goreczny GJ, Maynard A, Spasic M, McAllister SS. Abstract A18: Investigating CDK4/6 inhibition in triple-negative breast cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-A18 |
0.556 |
|
| 2020 |
McAllister SS. Abstract IA22: Pharmacologic and physiologic processes that affect response to immunotherapy Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Ia22 |
0.536 |
|
| 2019 |
Roweth HG, Malloy M, Goreczny G, Johnson KE, McAllister SS, Italiano JE, Battinelli E. Megakaryocyte Reprogramming in Breast Cancer. Blood. 134: 12. PMID 31724012 DOI: 10.1182/Blood-2019-124894 |
0.381 |
|
| 2019 |
Janiszewska M, Tabassum DP, Castaño Z, Cristea S, Yamamoto KN, Kingston NL, Murphy KC, Shu S, Harper NW, Del Alcazar CG, Alečković M, Ekram MB, Cohen O, Kwak M, Qin Y, ... ... McAllister SS, et al. Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments. Nature Cell Biology. 21: 879-888. PMID 31263265 DOI: 10.1038/S41556-019-0346-X |
0.434 |
|
| 2019 |
Sceneay J, Goreczny GJ, Wilson K, Morrow S, DeCristo MJ, Ubellacker JM, Qin Y, Laszewski T, Stover DG, Barrera V, Hutchinson JN, Freedman RA, Mittendorf EA, McAllister SS. Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. Cancer Discovery. PMID 31217296 DOI: 10.1158/2159-8290.Cd-18-1454 |
0.458 |
|
| 2019 |
Alečković M, McAllister SS, Polyak K. Metastasis as a systemic disease: molecular insights and clinical implications. Biochimica Et Biophysica Acta. Reviews On Cancer. 1872: 89-102. PMID 31202687 DOI: 10.1016/J.Bbcan.2019.06.002 |
0.551 |
|
| 2018 |
Castaño Z, San Juan BP, Spiegel A, Pant A, DeCristo MJ, Laszewski T, Ubellacker JM, Janssen SR, Dongre A, Reinhardt F, Henderson A, Del Rio AG, Gifford AM, Herbert ZT, Hutchinson JN, ... ... McAllister SS, et al. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nature Cell Biology. 20: 1084-1097. PMID 30154549 DOI: 10.1038/S41556-018-0173-5 |
0.431 |
|
| 2018 |
Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Hutchinson JN, Haider MT, Rhee CS, Qin Y, Gregory WM, Garrido-Castro AC, Holen I, Brown JE, Coleman RE, Scadden DT, ... McAllister SS, et al. Modulating bone marrow hematopoietic lineage potential to prevent bone metastasis in breast cancer. Cancer Research. PMID 30065048 DOI: 10.1158/0008-5472.Can-18-0548 |
0.473 |
|
| 2018 |
Goel S, DeCristo MJ, McAllister SS, Zhao JJ. CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest. Trends in Cell Biology. PMID 30061045 DOI: 10.1016/J.Tcb.2018.07.002 |
0.478 |
|
| 2018 |
Lee JJ, van de Ven RAH, Zaganjor E, Ng MR, Barakat A, Demmers JJPG, Finley LWS, Gonzalez Herrera KN, Hung YP, Harris IS, Jeong SM, Danuser G, McAllister SS, Haigis MC. Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3. Proceedings of the National Academy of Sciences of the United States of America. PMID 29915029 DOI: 10.1073/Pnas.1800440115 |
0.47 |
|
| 2018 |
Olive JF, Qin Y, DeCristo MJ, Laszewski T, Greathouse F, McAllister SS. Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies. Plos One. 13: e0198790. PMID 29897959 DOI: 10.1371/Journal.Pone.0198790 |
0.456 |
|
| 2018 |
DeCristo MJ, Goel S, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma C, Ramm S, Krop IE, ... ... McAllister SS, et al. Abstract B04: CDK4/6 inhibition triggers an antitumor immune response Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-B04 |
0.58 |
|
| 2018 |
Janiszewska M, Tabassum DP, Marusyk A, Ekram MB, Castaño Z, Kingston NL, Qin Y, Laszewski T, Kwak M, Nakamura K, Fan R, Michor F, McAllister SS, Polyak K. Abstract PR02: Minor clones can drive polyclonal metastasis by affecting immune microenvironment Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-Pr02 |
0.596 |
|
| 2018 |
Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Haider M, Rhee CS, Qin Y, Holen I, Gregory WM, Brown JE, Coleman RE, Scadden DT, McAllister SS. Abstract B13: Plasma G-CSF levels are predictive of lack of response to zoledronic acid treatment in reducing breast cancer recurrence Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B13 |
0.549 |
|
| 2018 |
McAllister SS, Sceneay J, Laszewski T, DeCristo M, Ubellacker J, Wilson K, Qin Y, Hutchinson J. Abstract 1737: Efficacy of immunotherapy is attenuated with age in triple-negative breast cancer Cancer Research. 78: 1737-1737. DOI: 10.1158/1538-7445.Am2018-1737 |
0.479 |
|
| 2017 |
Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma CX, Ramm S, Krop IE, ... ... McAllister SS, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. PMID 28813415 DOI: 10.1038/Nature23465 |
0.402 |
|
| 2017 |
Sceneay J, McAllister SS. The skinny on obesity and cancer. Nature Cell Biology. 19: 887-888. PMID 28752848 DOI: 10.1038/Ncb3583 |
0.356 |
|
| 2017 |
Ubellacker JM, Haider MT, DeCristo MJ, Allocca G, Brown NJ, Silver DP, Holen I, McAllister SS. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells. Breast Cancer Research : Bcr. 19: 23. PMID 28264701 DOI: 10.1186/S13058-017-0815-8 |
0.539 |
|
| 2017 |
DeCristo MJ, Goel S, Watt AC, BrinJones H, Sceneay J, Li B, Ubellacker JM, Xie S, Ramm S, Kim H, McAllister SS, Zhao JJ. Abstract 1634: CDK4/6 inhibition directly enhances an anti-tumor immune response in breast cancer Cancer Research. 77: 1634-1634. DOI: 10.1158/1538-7445.Am2017-1634 |
0.56 |
|
| 2016 |
Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, et al. Loss of RasGAP Tumor Suppressors Underlie the Aggressive Nature of Luminal B Breast Cancers. Cancer Discovery. PMID 27974415 DOI: 10.1158/2159-8290.Cd-16-0520 |
0.541 |
|
| 2016 |
Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A. Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling. Cancer Research. PMID 27940576 DOI: 10.1158/0008-5472.Can-16-2400 |
0.548 |
|
| 2016 |
Ubellacker JM, McAllister SS. The unresolved role of systemic factors in bone metastasis. Journal of Bone Oncology. 5: 96-99. PMID 27761365 DOI: 10.1016/J.Jbo.2016.03.009 |
0.358 |
|
| 2016 |
Marsh T, Wong I, Sceneay J, Barakat A, Qin Y, Sjödin A, Alspach E, Nilsson B, Stewart SA, McAllister SS. Hematopoietic Age at Onset of Triple-Negative Breast Cancer Dictates Disease Aggressiveness and Progression. Cancer Research. 76: 2932-2943. PMID 27197230 DOI: 10.1158/0008-5472.Can-15-3332 |
0.597 |
|
| 2016 |
McAllister SS. Abstract IA07: Systemic regulation of breast cancer progression Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-Ia07 |
0.621 |
|
| 2016 |
Ubellacker JM, McAllister SS. Abstract A67: Elucidating the impact of zoledronic acid on the bone microenvironment: Implications for breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A67 |
0.531 |
|
| 2016 |
DeCristo MJ, McAllister SS. Abstract A66: Systemic effects of AC-T chemotherapy in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A66 |
0.603 |
|
| 2016 |
Castano Z, Chaffer CL, Spiegel A, Pant A, Richardson AL, Reinhardt F, Marsh T, Janssen S, Gifford AM, Weinberg RA, McAllister SS. Abstract PR13: Understanding the systemic interactions between primary tumors and disseminated tumor initiating cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr13 |
0.588 |
|
| 2016 |
Sceneay J, Marsh T, Wong I, Qin Y, Sjödin A, Nilsson B, Stewart SA, McAllister SS. Abstract 4400: Hematopoietic age at onset of breast cancer dictates disease aggressiveness and progression Cancer Research. 76: 4400-4400. DOI: 10.1158/1538-7445.Am2016-4400 |
0.584 |
|
| 2015 |
Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, Soroceanu L. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death & Disease. 6: e1601. PMID 25590811 DOI: 10.1038/Cddis.2014.566 |
0.404 |
|
| 2015 |
Marsh T, Wong I, Barakat A, Qin Y, McAllister SS. Abstract PR11: Hematopoietic system aging has profound effects on the breast tumor microenvironment and cancer progression Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr11 |
0.588 |
|
| 2014 |
McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nature Cell Biology. 16: 717-27. PMID 25082194 DOI: 10.1038/Ncb3015 |
0.423 |
|
| 2014 |
Qin Y, McAllister SS. SPSB1 may have MET its match during breast cancer recurrence. Cancer Discovery. 4: 760-1. PMID 25002612 DOI: 10.1158/2159-8290.Cd-14-0505 |
0.541 |
|
| 2014 |
Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E, Donlin MJ, Marsh T, Piwnica-Worms D, Monahan J, Novack DV, McAllister SS, Stewart SA. p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discovery. 4: 716-29. PMID 24670723 DOI: 10.1158/2159-8290.Cd-13-0743 |
0.446 |
|
| 2014 |
Shaked Y, Mcallister S, Fainaru O, Almog N. Tumor dormancy and the angiogenic switch: Possible implications of bone marrow-derived cells Current Pharmaceutical Design. 20: 4920-4933. PMID 24283950 DOI: 10.2174/1381612819666131125153536 |
0.576 |
|
| 2013 |
Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. Journal of Internal Medicine. 274: 113-26. PMID 23844915 DOI: 10.1111/Joim.12084 |
0.511 |
|
| 2013 |
Castaño Z, Marsh T, Tadipatri R, Kuznetsov HS, Al-Shahrour F, Paktinat M, Greene-Colozzi A, Nilsson B, Richardson AL, McAllister SS. Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors. Cancer Discovery. 3: 922-35. PMID 23689072 DOI: 10.1158/2159-8290.Cd-13-0041 |
0.604 |
|
| 2013 |
Marsh T, Pietras K, McAllister SS. Fibroblasts as architects of cancer pathogenesis. Biochimica Et Biophysica Acta. 1832: 1070-8. PMID 23123598 DOI: 10.1016/J.Bbadis.2012.10.013 |
0.536 |
|
| 2013 |
Marsh T, Kuznetsov H, Markens B, Castano Z, Greene-Colozzi A, Hay S, Brown V, Richardson A, Signoretti S, Battinelli E, McAllister S. Abstract PR2: Identification of luminal breast cancers that establish a tumor supportive macroenvironment defined by proangiogenic platelets and bone marrow derived cells Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-Pr2 |
0.623 |
|
| 2013 |
Castano Z, Marsh T, Tadipatri R, Kuznetsov HS, Al-Shahrour F, Paktinat M, Greene-Colozzi A, Nilsson B, Richardson AL, McAllister SS. Abstract C94: Systemic and stromal support of triple-negative breast cancer progression is prevented by EGF and IGF-1 inhibitors Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C94 |
0.619 |
|
| 2012 |
Kuznetsov HS, Marsh T, Markens BA, Castaño Z, Greene-Colozzi A, Hay SA, Brown VE, Richardson AL, Signoretti S, Battinelli EM, McAllister SS. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discovery. 2: 1150-65. PMID 22896036 DOI: 10.1158/2159-8290.Cd-12-0216 |
0.629 |
|
| 2012 |
McAllister SS. Got a light? Illuminating lung cancer. Science Translational Medicine. 4: 142fs22. PMID 22786678 DOI: 10.1126/Scitranslmed.3004446 |
0.316 |
|
| 2012 |
Castaño Z, Fillmore CM, Kim CF, McAllister SS. The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Seminars in Cancer Biology. 22: 462-70. PMID 22548722 DOI: 10.1016/J.Semcancer.2012.04.006 |
0.573 |
|
| 2012 |
Castano Z, Marsh T, Tadipatri R, Kuznetsov H, Al-Sahour F, Paktinaz M, McAllister SS. Abstract 4861: Triple-negative breast cancers establish a systemic environment that drives malignant progression of otherwise indolent disseminated tumors via EGF and IGF Cancer Research. 72: 4861-4861. DOI: 10.1158/1538-7445.Am2012-4861 |
0.644 |
|
| 2011 |
Castaño Z, Tracy K, McAllister SS. The tumor macroenvironment and systemic regulation of breast cancer progression. The International Journal of Developmental Biology. 55: 889-97. PMID 22161844 DOI: 10.1387/Ijdb.113366Zc |
0.602 |
|
| 2011 |
Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. The Journal of Clinical Investigation. 121: 784-99. PMID 21266779 DOI: 10.1172/Jci43757 |
0.554 |
|
| 2010 |
McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4022-8. PMID 20644094 DOI: 10.1200/Jco.2010.28.4257 |
0.499 |
|
| 2009 |
McAllister SS, Scheel C, Nilsson B, Gifford AM, Reinhardt F, Bray M, Carpenter AE, Ebert BL, Weinberg RA. Abstract C75: Granulin‐expressing bone marrow cells promote the outgrowth of indolent tumors Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-C75 |
0.578 |
|
| 2008 |
Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell. 134: 62-73. PMID 18614011 DOI: 10.1016/J.Cell.2008.06.006 |
0.369 |
|
| 2008 |
McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell. 133: 994-1005. PMID 18555776 DOI: 10.1016/J.Cell.2008.04.045 |
0.511 |
|
| 2003 |
McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Molecular and Cellular Biology. 23: 216-28. PMID 12482975 DOI: 10.1128/Mcb.23.1.216-228.2003 |
0.334 |
|
| Show low-probability matches. |